Hemogenomics Pvt. Ltd. visits Naturn Medical Devices

On February 24th, 2025, Mr. Sumit Bagaria, the Managing Director & CEO of Hemogenomics Pvt. Ltd., paid a visit to Naturn Medical Devices. Hemogenomics, a pioneer in blood and cancer screening, and Naturn, leading in pathological devices, engaged in a productive exchange.

During the visit, comprehensive company and product introductions were followed by impressive demonstrations of Naturn's featured products. Mr. Bagaria was particularly drawn to the Tissue Microarrayer, Slide Stainer, and Raid Decalcifying Station. Their originality, cutting-edge technology, and competitiveness left a deep impression. The Tissue Microarrayer creates perfect tissue microarrays efferently, while the Slide Stainer ensures consistent staining results for frozen sections. The Rapid can quickly remove calcium from hard tissues and preserve molecular meanwhile.

This visit has set the stage for prospective collaboration. By combining Hemogenomics' know-how and Naturn's expertise, we are expecting revolutionary development and breakthrough, and more exciting news from this potential partnership